Status:
COMPLETED
Fiberoptic Bronchoscopy in Severe Ventilator-associated Pneumonia
Lead Sponsor:
Benha University
Conditions:
Ventilator-Associated Pneumonia
Severe Pneumonia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This randomized controlled trial evaluated the clinical effect of fiberoptic bronchoscopy in the management of adult patients with severe ventilator-associated pneumonia (VAP). A total of 100 patients...
Eligibility Criteria
Inclusion
- Adults aged 18-65 years
- Patients of both sexes
- Patients requiring mechanical ventilation
- Development of pneumonia ≥ 48 hours after endotracheal intubation or ≥ 48 hours after extubation
- Diagnosis of severe ventilator-associated pneumonia defined by a Modified Clinical Pulmonary Infection Score (CPIS) \> 6
Exclusion
- Refusal to participate
- Presence of lung shadows prior to mechanical ventilation
- Severe bleeding disorders or immune system diseases
- Severe hemodynamic instability
- Recent myocardial infarction or unstable arrhythmia
- Tracheal stenosis or upper airway mass
Key Trial Info
Start Date :
December 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07149909
Start Date
December 15 2023
End Date
December 15 2024
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha University
Banhā, Benha, Egypt, 13511